Regulatory T cells in Graves' disease

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• Graves' disease (GD) is an autoimmune disorder targeting thyroid cells, but the precise triggers for this autoimmunity remain unclear.
• Regulatory T cells (Tregs) play a crucial role in maintaining immune tolerance and preventing autoimmune responses.

Purpose of the Study:

• To investigate whether a deficiency in regulatory T cells contributes to the development or progression of active Graves' disease.
• To assess Treg numbers and function in patients with active GD compared to healthy controls and post-treatment patients.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) were isolated from patients with active GD, treated GD patients, and healthy controls.
• Regulatory T cells were enumerated using Fluorescent Activated Cell Sorting (FACS).
• Gene expression analysis (real-time PCR) was performed for key Treg-related genes (e.g., FoxP3, GITR, CD25) in PBMCs.

Main Results:

• The distribution and number of regulatory T cells (CD4+CD25+CD127+lo) were comparable between active GD patients and control subjects.
• While some Treg-related gene expression (Gadd45 alpha/beta, GITR, CD25) was elevated in active GD, FoxP3 mRNA levels were similar to controls.
• Treated patients showed similar or higher Treg gene expression compared to controls.

Conclusions:

• The study concludes that there is no evidence of a regulatory T cell deficit in patients with active Graves' disease.
• These findings suggest that Treg deficiency is unlikely to be the primary cause of GD autoimmunity.
• Treg numbers and function appear to be maintained even during active disease and after treatment.